messa (Skeden i kliniskkemi iFinland). SuomenLääkä–
rilehti 1975;30:1509-1515.
4. GräsbeckR,SarisN-E. Establishment and use ofnor–
mal values. Scand J clinLab Invest 1969;Supp1 110:62-
63.
5. Leskinen E. NORDKEM. Nordiskt samprojekt för
klinisk kemi. Historik 1977-1994.Utgiven avNordkems
sekretariat, Helsingfors 1995.
6. Saris N-E, Nuutinen M, Närvänen S. Maamme kli–
inisten laboratorioiden ana1yysitu1osten vaihte1u (skill–
nader mellan våra kliniska skiftande laboratorieresul–
tat). Duod 1967;83:1104-1111.
7. NikkiläEA, Jokipii SG. Effecton serum lipids ofsupp-
1ementation of diet with po1yunsaturated fat. A study
28
with aged human subjects. Acta Med Scand 1960;
166:269-274.
8. LuukkainenT, Lähteenmäki P,Toivonen J. Levonor–
gestrel-re1easing intrauterine device. Ann Med
1990;;22:85-90.
9. Adlercreutz H. Phytoestrogens: Epidemiology and a
possible roel in cancer protection.EnviranHealthPersp
1995;103:103-112.
10. Gräsbeck
R.
Studies on theVitaminB
12
-bindingprin–
cip1e and other biocoliaids of human gastric juice. Acta
Med Scand 1960; Supp1314:1-87 (Dissertation).
11. Lamberg B-A. Endemic goitre in Finland and chan–
ges during 30 years of iodine prophylaxis. Endocrinol
Exper 1986;20:35-47.
Klinisk Kemi
i
Norden Supplemem, 1997
